摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4'-(Hydroxymethyl)adenosin | 63070-09-7

中文名称
——
中文别名
——
英文名称
4'-(Hydroxymethyl)adenosin
英文别名
(3S,4R,5R)-5-(6-aminopurin-9-yl)-2,2-bis(hydroxymethyl)oxolane-3,4-diol
4'-(Hydroxymethyl)adenosin化学式
CAS
63070-09-7
化学式
C11H15N5O5
mdl
——
分子量
297.271
InChiKey
WBNQTEKLVXXLQW-MATHAZKKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.9
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    160
  • 氢给体数:
    5
  • 氢受体数:
    9

文献信息

  • 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
    申请人:——
    公开号:US20020086850A1
    公开(公告)日:2002-07-04
    There are provided according to the invention novel compounds of formula I 1 wherein R 1 , R 2 and R 3 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    根据本发明提供了一种新型化合物,其化学式为I1,其中R1、R2和R3如规范中所述,还提供了制备这些化合物的方法、含有它们的配方以及它们在治疗炎症性疾病中的用途。
  • 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
    申请人:GLAXO GROUP LIMITED
    公开号:EP1051425B1
    公开(公告)日:2002-10-30
  • 2-(PURIN-9-YL)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
    申请人:GLAXO GROUP LIMITED
    公开号:EP1090020B1
    公开(公告)日:2003-11-05
  • 4'-SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF HCV RNA REPLICATION
    申请人:Devos Rene Robert
    公开号:US20100003213A1
    公开(公告)日:2010-01-07
    The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.
  • 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
    申请人:Martin Joseph Armstrong
    公开号:US20100004192A1
    公开(公告)日:2010-01-07
    The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.
查看更多